Complete DiGeorge Syndrome
Also known as: Complete Typical DiGeorge Anomaly / Complete DiGeorge Anomaly
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00098 | Antithymocyte immunoglobulin (rabbit) | 1 / 2 | Completed | 1 |
| DB00091 | Cyclosporine | 1 / 2 | Completed | 1 |
| DB00111 | Daclizumab | 1 / 2 | Completed | 1 |
| DB00959 | Methylprednisolone | 1 / 2 | Completed | 1 |
| DB00688 | Mycophenolate mofetil | 1 / 2 | Completed | 1 |
| DB00860 | Prednisolone | 1 / 2 | Completed | 1 |
| DB00864 | Tacrolimus | 1 / 2 | Completed | 1 |
| DB16736 | Allogeneic processed thymus tissue | Not Available | Recruiting | 1 |
| DB00091 | Cyclosporine | Not Available | Approved for Marketing | 1 |
| DB00959 | Methylprednisolone | Not Available | Approved for Marketing | 1 |
| DB00688 | Mycophenolate mofetil | Not Available | Approved for Marketing | 1 |
| DB00860 | Prednisolone | Not Available | Approved for Marketing | 1 |
| DB00864 | Tacrolimus | Not Available | Approved for Marketing | 1 |